The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.

Trial Profile

The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 30 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 20 Jan 2013 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 20 Sep 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top